Patents by Inventor Yulu DAI

Yulu DAI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Acylated derivative of human insulin or analogue thereof
    Patent number: 10815287
    Abstract: Provided is an acylated derivative of human insulin or an analogue thereof. Specifically disclosed is an acylated derivative of a human insulin analogue, or zinc complex thereof; the human insulin analogue being derivatized is preferably Des(B30) human insulin; the acylated derivative is longer-lasting than existing insulin analogues and acylated derivatives thereof, its blood glucose reduction is more steady, and it is more stable in storage.
    Type: Grant
    Filed: August 1, 2017
    Date of Patent: October 27, 2020
    Assignee: JIANGSU HENGRUI MEDICINE CO., LTD.
    Inventors: Deyu Liu, Hongwei Wang, Liang Zhao, Feifei Wang, Xiang Zeng, Tao Wang, Yali Wang, Yulu Dai
  • ACYLATED DERIVATIVE OF HUMAN INSULIN OR ANALOGUE THEREOF
    Publication number: 20190169257
    Abstract: Provided is an acylated derivative of human insulin or an analogue thereof. Specifically disclosed is an acylated derivative of a human insulin analogue, or zinc complex thereof; said acylated derivative is longer-lasting than existing insulin analogues and acylated derivatives thereof, its blood glucose reduction is more steady, and it is more stable in storage.
    Type: Application
    Filed: August 1, 2017
    Publication date: June 6, 2019
    Applicant: JIANGSU HENGRUI MEDICINE CO., LTD.
    Inventors: Deyu LIU, Hongwei WANG, Liang ZHAO, Feifei WANG, Xiang ZENG, Tao WANG, Yali WANG, Yulu DAI